Biotech Sector Performance February 2014: Red Hot But...
IBB data by YCharts Recall, the IBB was +8% at the end of January.
About Friday's selloff. This is what it looks like mapped against the entire week's trading. We've seen dips like this before in the biotech bull market and they were all bought aggressively. Monday's trading will be interesting to watch.
IBB data by YCharts
Here's how the big-cap biotechs are performing year to date:
CELG data by YCharts The best-performing biotech and drug stocks after two months of 2014:
1. Intercept Pharma (ICPT - Get Report) + 501%
2. Tekmira Pharma (TKMR - Get Report) +166%
3. Rexahn Pharma (RNN)+165%
4. Imprimis Pharma (IMMY) +157%
5. Retrophin Pharma (RTRX - Get Report) +152%